HomeNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Previous close
$0.44
Day range
$0.27 - $0.48
Year range
$0.17 - $0.54
Market cap
400.61M USD
Avg Volume
4.04M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 231.00K | -48.09% |
Operating expense | 8.21M | 0.91% |
Net income | -28.22M | -101.92% |
Net profit margin | -12.22K | -288.99% |
Earnings per share | — | — |
EBITDA | -18.06M | -22.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.18M | 2.30% |
Total assets | 26.73M | -4.08% |
Total liabilities | 105.71M | 41.09% |
Total equity | -78.98M | — |
Shares outstanding | 1.39B | — |
Price to book | -6.25 | — |
Return on assets | -165.03% | — |
Return on capital | 530.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -28.22M | -101.92% |
Cash from operations | -20.18M | -19.01% |
Cash from investing | -78.00K | 81.34% |
Cash from financing | 15.94M | 10.59% |
Net change in cash | -764.00K | 80.76% |
Free cash flow | -7.97M | 23.95% |
